INTRODUCTION
Sequence alignment of members of the sugar transporter superfamily suggest that a gene encoding an ancestral six-membranespanning helical protein may have produced, in the evolutionary process, a two-domain 12-membrane-spanning helical structure [1] [2] [3] [4] . Domain assembly experiments [5, 6] , and mutagenesis experiments [7] suggest that both the N-and C-terminal halves of the transport proteins are necessary for function. However, photolabelling studies involving active-site ligands suggest that the bis-mannose compound, 2-N-4-(1-azi-2,2,2-trifluoroethyl)-benzoyl-1,3-bis-(D-mannos-4-yloxy)-2-propylamine (ATB-BMPA) (an exofacial ligand), cytochalasin B (an endofacial ligand) and 3-iodo-4-azidophenethylamino-7-0-succinyldeacetyl-forskolin (IAPS-forskolin) interact only with the Cterminal half of GLUT1 [8] [9] [10] [11] . The N-terminal half of GLUTI may therefore be responsible for stabilizing the C-terminal half in a ligand-binding conformation [6] .
Mutagenesis and proteolysis can stabilize either inwarddirected or outward-directed conformational states of the GLUT1 protein. We have recently shown [12] that substitution of Tyr-293 by isoleucine stabilizes an outward-directed conformation which retains high affinity for the exofacial ligand ATB-BMPA, but which totally loses the ability to bind cytochalasin B at the endofacial site. C-terminal truncation of 37 amino acids from GLUT1 has been shown [13] to produce a protein that is stabilized in an inward-directed conformation. This mutant GLUT1 could not bind the exofacial ligand ATB-BMPA, but retained cytochalasin B binding. Similarly, the 18 kDa proteolytic fragment of GLUT1, which has lost an approx. 4 kDa portion of the C-terminus, has reduced affinity for ATB-BMPA but binds cytochalasin B well [14] . Stabilizing the GLUTI in either the outward-directed or inward-directed conformational state results in reduced glucose transport catalysis.
We have suggested [15] that conformational flexibility in the glycine-and proline-rich transmembrane segment (TM) 10 is essential for the transport catalysis process. Substitution of isoleucine for Pro-385 sterically reduces flexibility and glucose transport while retention of flexibility, by substitution of glycine for Pro-385, allows conformational alternation between the Abbreviations used: ATB-BMPA, 2-N-4-(1-azi-2,2,2-trifluoroethyl)benzoyl-1,3-bis(D-mannos-4-yloxy)-2-propylamine; CHO Osguthorpe and G. D. Holman, unpublished work) suggest that in the outward-directed conformation, the base of TM 12 (the C-terminal segment) packs against the base ofTM 10 and thereby blocks cytochalasin B binding. Thus deletion of critical residues in the C-terminus may prevent the closing of the inner site and the consequent opening of the outer site. The deletion of 37 amino acids but not 12 amino acids locks the GLUT1 in the inward-facing conformation [13, 16] . In order to establish the minimum size of truncation that would produce a perturbation of glucose transport activity and the associated inability to expose the outward-facing site, we have constructed a series of C-terminal mutants of GLUT1 which have from 24 to 37 amino acid deletions and we have studied the transport and ligand-binding characteristics in CHO-KI clones expressing these constructs. Preliminary studies indicated that truncated GLUTIs in which 31,34 and 37, but not 24, amino acids were deleted from the C-terminus were expressed in the cell, as detected by Western blotting, at levels comparable with the wild type, but that they had impaired 2-deoxy-D-glucose transport activity. Subsequent studies, described here, focused on the region around the highly conserved residues Phe-467 and Arg-468 (the CTD26 and CTD25 deleted GLUTls, respectively) for further study. During the course of this work, a preliminary study by Due and May suggested that 21 amino acids could be deleted from the Cterminus of GLUTI without loss of function [17] .
The residues Phe-467 and Arg-468 have been mutated to leucine to test the possibility that these amino acids are individually critical for glucose transport. In addition we have also tested the possibility that the introduction of the glutamate in GLUT2 (a high Km transporter) at the equivalent of Gly-466 in GLUTI may alter the Km. [18] . The template for mutagenesis was prepared in Escherichia coli RZ1032. Construction of truncation mutants was carried out by using the mutagenic primer, 5'-GCTCCCC-CCTACCGGAAGCCG-3' for Gln-469, 5'-CTCCCCCCTGCT-AGAAGCCG-3' for Arg-468, 5'-CCCTGCCGCTAGCCGGA-AGC-3' for Phe-467 and 5'-CTGCCGGAATCAGGAAGCG-ATC-3' for Gly-466 thereby converting the base triplets coding for these amino acids into stop codons. For point mutations G466E, F467L and R468L the oligonucleotides 5'-CCCCTG-CCGGAATTCGGAAGCGATC-3', 5'-CCCTGCCGGAGGC-CGGAAGCGATC-3' and 5'-CCCCCCTGCAGGAAGCCGG-AAG-3' were used. Suitable mutant clones were selected and their sequences were confirmed by dideoxy-nucleotide sequencing in M13. Resultant cDNAs were designated CTD24, CTD25, CTD26 and CTD27, respectively. The mutated fragments were reinserted either into the NheI/XbaI site (for CTD27, CTD25, CTD24, G466E, F467L and R468L) or the BstEII/XbaI site (for CTD26) of the previously constructed pRC/CMV-GTl(WT) [19] . pRC/CMV-GTl(WT) contains the vector pRC/CMV containing the human cytomegalovirus IEI promoter and the bacterial neomycin resistance gene fused to the SV40 promoter. Mutant GLUTI cDNAs were transfected by the calcium phosphate method into CHO-KI cell lines, which were maintained in Ham's F-12 medium containing 10 % (v/v) fetal-calf serum. The clones which obtained neomycin resistance were selected with 600 ,ug/ml of the neomycin derivative G418 (GIBCO) and these clones were subsequently subjected to Western blotting analysis using anti-peptide antibody against the intracellular loop portion of human GLUTI to identify clones which express similar amounts of protein to the wild-type clone.
EXPERIMENTAL

Western blot analysis
This was carried out essentially as described previously [19] except that both an anti-(C-terminal) antibody [19] and an antibody raised against the peptide CLINRNEENRAKS (corresponding to residues 215-226 in the central loop region [13] ) were used.
Assays of glucose transport activity In CHO-Ki cells
Cells in 24-well (16-mm-diam.) plates were grown to confluence for 2-3 days and then washed three times in Krebs-Ringer phosphate buffer (KRPB) containing 130 mM NaCl, 5 mM KCl, 1.3 mM CaCl2, 1.3 mM MgSO4 and 10 mM Na2HPO4, pH 7.4. 2-Deoxy-[2,6-3H]D-glucose was then added to give a final assay concentration of 0. 1-10 mM in 0.5 ml of KRPB and incubated at 37 'C. Uptake was terminated at 10 min, or 1 min (for experiments in which Km and Vmax were determined), by an addition of 1 ml/well of ice-cold PBS containing 0.3 mM phloretin, followed by three rapid washes in ice-cold PBS/phloretin. Following the arrest of transport, cells were solubilized with 0.4 ml of 0.1 % SDS and the extract was added to scintillant for estimation of radioactivity. Zero-time uptake was determined by adding phloretin before the transported substrate.
Labelling of transporter cell-surface carbohydrate with tritiated sodium borohydride This procedure was carried out as previously described in detail [19] . In brief, confluent cells in 35-mm-diam. dishes were simultaneously treated with 10 units of galactose oxidase and 1 unit of neuraminidase followed by 1 mCi of tritiated sodium borohydride (specific radioactivity 13.4 Ci/mmol). The cells were solubilized in detergent buffer consisting of 2% C12E9 in PBS, pH 7.2, with the proteinase inhibitors antipain, aprotinin, pepstatin A and leupeptin, each at 1 ug/ml. The solubilized material was then subjected to immunoprecipitation by Protein A-Sepharose coupled with anti-(GLUTI central loop) serum. The immunoprecipitates were solubilized in electrophoresis sample buffer containing 10 % SDS, 6 M urea and 10 % mercaptoethanol and were subjected to electrophoresis on 10 % acrylamide gels using a discontinuous buffer system [20] . Radioactivity in the gel slices was extracted and quantified as described previously [19] . [14, 21] . Following irradiation the dishes were washed five times in PBS and directly solubilized in SDS/ electrophoresis sample buffer, subjected to electrophoresis on 10% acrylamide gels and then the radioactivity associated with the gel peaks was determined. [19] . Quantification of the Western blots (Table 1) showed that the expression levels in these clones were approx. 10-fold higher than for the non-transfected CHO-KI clone. The bands corresponding to the truncated glucose transporter proteins showed only slight differences in their migration and apparent molecular mass on SDS/PAGE in comparison with the wild-type proteins. When Western blotting was carried out with an anti-peptide antibody directed against residues 478-492 of the C-terminus of GLUT1 [19] then only the wild-type GLUT1 protein was observed and no bands were detected for the four mutant clones lacking the C-terminal epitope (Figure lb) . A representative experiment showing the results following cellsurface labelling of the CTD24 and CTD26 clones is shown in Figure 2 . The collected results from labelling all four clones in a series of experiments are shown in Table 1 . Using this technique, all four truncated GLUTI clones were confirmed to be expressed at the cell surface at levels that were similar to that occurring in the wild-type clone. By contrast, the CHO-K I clone was labelled to a level which was only 13 % of the wild-type clone.
RESULTS
2-Deoxy-D-glucose uptake measurements in the truncated clones revealed that only the CTD24 clone retained transport activity which was similar to that of the wild-type clone ( Table  1 ). The remaining three mutant clones showed reductions in hexose transport. These were 55.3 + 3.4 % (n = 4) for CTD25, 36.3+1.7% (n=4) for CTD26, and 22.6+0.8% (n=4) for CTD27 of that occurring in the wild type. The transport activity in the CTD27 clone was similar to that observed in the nontransfected clone. To analyse the change in transport in more detail we investigated the kinetics of 2-deoxy-D-glucose net uptake at a range of substrate concentrations in the CTD24 and CTD26 clones (Figure 3) . The most marked kinetic change due to the deletion was a reduction in the Vmax value. In this series of experiments, the Vmax of the wild type was 80.6 + 10.6 nmol/min per mg of protein. The Vmax for 2-deoxy-D-glucose transport in the CTD24 clone (68.2 + 5.9 nmol/min per mg of protein) was similar to that of the wild type. By contrast the Vmax for the CTD26 clone was 17.1 + 2.3 nmol/min per mg of protein. The A values, which were similar in the wild-type and CTD24 clones, were 1.7 + 0.2 mM and 1.30 + 0.4 mM respectively, and were slightly lower in the CTD26 clone, in which the Km was 0.75 + 0.04 mM. These results are the mean + S.E.M. from three separate experiments.
In a separate series of experiments (Table 1) amino acid substitutions were introduced, on the basis of these results and their strong conservation in the glucose transporter superfamily, into presumably important amino acids, i.e. Gly-466, Phe-467, and Arg-468. Also the effects on the kinetics of 2-deoxy-Dglucose uptake of point mutations at G466 -+ E, F467 -* L and R468 -+ L were examined to further analyse the possibility that these amino acids are individually critical for glucose transport. Surprisingly, no large reductions in 2-deoxy-D-glucose transport were observed. However, a small but consistent reduction in the Km of 2-deoxy-D-glucose transport was observed for the R468 L mutant.
To analyse further the characteristics of the truncated transporters with perturbed function, the ligand-binding ability of these transporters was assessed using photolabelling procedures with the exofacial-site-specific reagent, ATB-BMPA, and with the internal-site-specific reagent, cytochalasin B. The labelling of the CTD24 clone by ATB-BMPA was similar to that of the wild type (Figure 4a ). The ligand labelling at the exofacial site was only markedly reduced as a result of the deletion of the Arg-468 residue, and the CTD25 clone was labelled by ATB-BMPA to a level which was 12.5 + 1.6 % (n = 3) of that observed with the (GLUT1 C-terminus) antibody. wild-type clone. A further reduction occurred on removal of Phe-467, i.e. the CTD26 clone. In this clone the labelling was 6.4 + 1.5 % (n = 3) of that of the wild type and was comparable with that occurring in the non-transfected CHO-KI clone (6.8+0.4%, n = 3).
As shown in the representative experiment in Figure 4(b) , the cytochalasin B labelling of the CTD24 and CTD26 clones was unperturbed as a result of the C-terminal truncation. The collected results from a series ofexperiments on all four truncated clones (Table 1) showed cytochalasin B labelling in all these clones was similar to that of the wild-type clone and this labelling was approx. 7-fold higher than that of the non-transfected CHO-K1 clone.
DISCUSSION
The data presented here suggest that the C-terminal 24 amino acids of GLUT1 are not required for the transport catalysis process or the exofacial ligand-binding function of this protein. This does not necessarily exclude the possibility that these amino acids may be required as part of a targeting sequence that may be recognized by a possible subcellular sorting system in other cell types, as has been suggested for the N-terminal [22] and Cterminal sections of GLUT4 [23, 24] . If such a system is present in CHO cells then the ability of the C-terminally truncated mutants of GLUT1 to be expressed at the cell surface at similar levels to the wild-type protein suggests that these C-terminal which these residues are converted into lecine residues produce GLUTI clones with fast rates of transport. This suggests that the truncation at these positions may perturb transport because the C-terminus is too short to produce the normal conformational change associated with alternating between the inner-and outer-facing sites in the transport catalysis cycle. We have suggested [15] that, in order to produce the outward-directed conformation, the base of TM 12, the C-terminal segment packs against the base of TM 10. Studies in which stable inward-and outward-directed conformations result from binding side-specific hexose ligands, from proteolytic digestion and from mutagenesis, all support the alternating conformational model [25, 26] as a mechanistic basis of transport catalysis. It has been suggested that some kinetic alterations of this basic mechanism could occur in an oligomeric form of the transporter [27] . Whatever the details of the conformational change associated with transport catalysis, results presented here lead to the suggestion that a minimum structure required for this process is an extension to residues 467 and 468, although these residues are not individually essential.
Katagiri et al. [28] further interpretation of these results. The C-terminal sequences of GLUTI and GLUT2 in the critical region around residues Phe-467 and Arg-468 are as shown in Figure 5 .
The chimeric protein is rabbit GLUTI up to Glu454 and then has the sequence of human GLUT2. The truncations of GLUTI that have no effect on function occur after Arg-468. Apart from conservative substitutions, the major difference between the wild-type GLUT1 and the GLUT1/GLUT2 chimeric protein occurs at the SG residues in GLUTI which are AE in the chimeric protein. In order to test whether the possibility that the substitution of a neutral residue by an acidic residue at position 466 could be responsible for the high Km and high Vmax, a GLUT G466 -. E point mutation was constructed. However, this mutation did not produce a high Km phenotype. This leaves the possibility that residues of GLUT2 that correspond to the deleted 24 amino acids of GLUTI may be involved. If this effect occurs then it may be due to the additional basic residues, LysLys, occurring after Phe-467 and Arg-468. Consistent with this possibility we note that replacing the basic Arg-468 by leucine and truncation of Arg-468 (the CTD 25-CTD27 mutants) produces a small but consistent reduction in the Km for transport. The basic arginine residue, Arg-468, may become less critical when Lys-Lys occurs in this C-terminal region as Gln can substitute for Arg in human GLUT2. An alternative explanation for the high Km phenotype may be that the increased length of the GLUT2 C-terminus beyond positions 467 and 468 could be 
